| RAB03810
| CoV-2/COVID-19 Spike Glycoprotein recombinant monoclonal antibody, clone CR3022
| 100 ug
| Abnova
|
|
|
|
| Request Quotation
| Request
|
| RAB01043
| SARS-CoV/SARS-CoV-2 S recombinant human antibody, clone CR3022
| 100 ug
| Abnova
|
|
|
|
| Request Quotation
| Request
|
| Ab01680-16.0-BT
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 500 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-10.7-BT
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 500 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-3.3
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 200 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-10.6-BT
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 500 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-46.0-ISS
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 100 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-10.3
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 200 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-10.3-BT
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 1 mg
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-1.6
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 100 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-10.6-BS
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 1 mg
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-10.6
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 100 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-1.6-BS
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 1 mg
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-3.3-BT
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 1 mg
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-46.0-IST
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 50 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-10.7
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 100 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-49.0
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 50 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-13.12
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 200 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-10.0
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 200 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-12.1
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 200 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-21.0-BT
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 500 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-200.0-BT
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 500 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-49.0-BT
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 500 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-200.0
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 50 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-15.0
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 50 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-21.0
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 50 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-16.0
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 50 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-3.0
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 200 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-14.0-BT
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 500 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-11.0
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 200 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-1.7-BS
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 1 mg
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-13.12-BT
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 1 mg
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-45.1-BT
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 1 mg
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-12.1-BT
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 1 mg
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-44.0-BT
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 500 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-48.1-BT
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 1 mg
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-48.1
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 200 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-23.0
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 200 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-14.0
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 50 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-15.0-BT
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 500 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-11.0-BT
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 1 mg
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-45.1
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 200 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-23.0-BT
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 1 mg
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-44.0
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 50 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-3.0-BT
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 1 mg
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-10.0-BT
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 1 mg
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-1.7
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 100 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-1.7-BT
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 500 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-10.7-BS
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 1 mg
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01680-1.6-BT
| Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]
| 500 ug
| Absolute Antibody
| ELISA; NTRL; SPR; Crystallography; IF
|
|
| Other
| Request Quotation
| Request
|